MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s13075-019-1999-3

Медицинская библиотека · Arthritis research & therapy · 2019

Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor.

Farutin Victor, Prod'homme Thomas, McConnell Kevin, Washburn Nathaniel, Halvey Patrick, Etzel Carol J, Guess Jamey, Duffner Jay, Getchell Kristen, Meccariello Robin, Gutierrez Bryan, Honan Christopher, Zhao Ganlin, Cilfone Nicholas A, Gunay Nur Sibel, Hillson Jan L, DeLuca David S, Saunders Katherine C, Pappas Dimitrios A, Greenberg Jeffrey D, Kremer Joel M, Manning Anthony M, Ling Leona E, Capila Ishan

Клиническое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The goal of this study is to use comprehensive molecular profiling to characterize clinical response to anti-TNF therapy in a real-world setting and identify reproducible markers differentiating good responders and non-responders in rheumatoid arthritis (RA).

METHODS

Whole-blood mRNA, plasma proteins, and glycopeptides were measured in two cohorts of biologic-naïve RA patients (n = 40 and n = 36) from the Corrona CERTAIN (Comparative Effectiveness Registry to study Therapies for Arthritis and Inflammatory coNditions) registry at baseline and after 3 months of anti-TNF treatment. Response to treatment was categorized by EULAR criteria. A cell type-specific data analysis was conducted to evaluate the involvement of the most common immune cell sub-populations. Findings concordant between the two cohorts were further assessed for reproducibility using selected NCBI-GEO datasets and clinical laboratory measurements available in the CERTAIN database.

RESULTS

A treatment-related signature suggesting a reduction in neutrophils, independent of the status of response, was indicated by a high level of correlation (ρ = 0.62; p < 0.01) between the two cohorts. A baseline, response signature of increased innate cell types in responders compared to increased adaptive cell types in non-responders was identified in both cohorts. This result was further assessed by applying the cell type-specific analysis to five other publicly available RA datasets. Evaluation of the neutrophil-to-lymphocyte ratio at baseline in the remaining patients (n = 1962) from the CERTAIN database confirmed the observation (odds ratio of good/moderate response = 1.20 [95% CI = 1.03-1.41, p = 0.02]).

CONCLUSION

Differences in innate/adaptive immune cell type composition at baseline may be a major contributor to response to anti-TNF treatment within the first 3 months of therapy.

Для цитирования: Farutin Victor, Prod'homme Thomas, McConnell Kevin, Washburn Nathaniel, Halvey Patrick, Etzel Carol J, Guess Jamey, Duffner Jay, Getchell Kristen, Meccariello Robin, Gutierrez Bryan, Honan Christopher, Zhao Ganlin, Cilfone Nicholas A, Gunay Nur Sibel, Hillson Jan L, DeLuca David S, Saunders Katherine C, Pappas Dimitrios A, Greenberg Jeffrey D, Kremer Joel M, Manning Anthony M, Ling Leona E, Capila Ishan. Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor.. Arthritis research & therapy. 2019. DOI: 10.1186/s13075-019-1999-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.